Meclizine: Indications and Dosing
Meclizine is FDA-approved for treating vertigo associated with vestibular system diseases in adults, with a recommended dosage of 25-100 mg daily in divided doses, though recent evidence suggests it may increase fall risk and should be used cautiously. 1
FDA-Approved Indication
Meclizine hydrochloride is indicated specifically for treatment of vertigo associated with diseases affecting the vestibular system in adults. 1 This is the only FDA-approved indication for this medication.
Dosing Recommendations
Standard Dosing for Vertigo
- Dose range: 25 mg to 100 mg daily, administered orally in divided doses
- Titration: Adjust based on clinical response
- Administration: Tablets must be swallowed whole 1
Available Strengths
- 12.5 mg tablets
- 25 mg tablets
- 50 mg tablets 1
Pediatric Dosing (Investigational)
In research settings for achondroplasia:
Off-Label Uses
Postoperative Nausea and Vomiting (PONV)
A biphasic regimen showed effectiveness:
- 50 mg orally the night before surgery
- 50 mg orally on the day of surgery
- This regimen demonstrated efficacy in high-risk PONV patients when combined with intraoperative ondansetron 4 mg IV 4
Motion Sickness
Meclizine is commonly used over-the-counter for motion sickness prevention, though this was not the primary focus of the FDA label provided. 5
Critical Safety Warnings
Fall Risk - Major Concern
Recent evidence reveals a significant association between meclizine use and injurious falls, even in younger adults:
- Ages 18-64 years: Hazard ratio 2.94 (95% CI: 2.81-3.08) for falls
- Ages ≥65 years: Hazard ratio 2.54 (95% CI: 2.42-2.66) for falls
- 9% of meclizine users experienced injurious falls requiring medical evaluation 6
This finding is particularly concerning because it contradicts the common perception of meclizine as a benign medication and suggests its use may be guideline-discordant for many vestibular conditions. 6
Other Warnings
- Drowsiness: Patients must avoid driving and operating machinery; avoid alcohol 1
- Anticholinergic effects: Use with caution in patients with:
- Asthma
- Glaucoma
- Prostatic enlargement 1
Drug Interactions
CNS Depressants
Concurrent use with alcohol or other CNS depressants increases sedation risk 1
CYP2D6 Inhibitors
Meclizine is metabolized by CYP2D6; monitor for adverse reactions when co-administered with CYP2D6 inhibitors 1
Contraindications
Absolute contraindication: Hypersensitivity to meclizine or any inactive ingredients 1
Common Adverse Reactions
- Drowsiness (most common)
- Dry mouth
- Headache
- Fatigue
- Vomiting
- Blurred vision (rare)
- Anaphylactic reaction (rare) 1
Clinical Considerations
Comparative Effectiveness
For acute peripheral vertigo in the emergency department, meclizine 25 mg and diazepam 5 mg showed equivalent efficacy with no significant difference in symptom improvement at 60 minutes (mean VAS improvement: 40 vs 36, p=0.60). 7
Pharmacokinetics
- Tmax: 1.7-3.7 hours
- Half-life: 7.4-8.5 hours
- Steady state: Achieved approximately 10 days after first dose
- Food effect: Increased exposure with food (AUC increased from 504 to 813 ng·h/mL) 3
Key Pitfall to Avoid
Do not prescribe meclizine routinely for dizziness without considering fall risk, especially in older adults or those with fall history. The association with increased falls suggests this medication may cause more harm than benefit in many patients with vestibular complaints, despite providing short-term symptom relief. 6 Consider vestibular rehabilitation therapy as a safer alternative for appropriate vestibular diagnoses.